ABERDEEN, Scotland--(BUSINESS WIRE)--NovaBiotics Ltd (“NovaBiotics” or the “Company”), announces that Woodford Investment Management LLP (“Woodford IM”) has invested £5.0 million (gross) in a private placement. The funds will provide working capital to enable NovaBiotics to achieve key value enhancing milestones in the short to mid-term. The priority for the business is driving forward the Company’s clinical stage, first-in-class antimicrobial therapeutics assets. NovaBiotics is also focused on further developing its earlier stage antifungal and antibacterial compounds and the anti-infective peptide platform from which these molecules have been derived.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
